Millennium Management’s AstraZeneca AZN Stock Holding History

Millennium Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$57.2M	Sell	69,700 -91,200	-57%	-$17.6M	0.02%	749
2025 Q4	$29.6M	Sell	160,900 -1,550	-1%	-$272K	0.01%	1201
2025 Q3	$24.9M	Buy	162,450 +142,800	+727%	+$21.6M	0.01%	1435
2025 Q2	$2.75M	Sell	19,650 -292,750	-94%	-$41M	﹤0.01%	3599
2025 Q1	$45.9M	Buy	312,400 +240,550	+335%	+$34.8M	0.02%	840
2024 Q4	$9.42M	Sell	71,850 -324,700	-82%	-$45.5M	﹤0.01%	2241
2024 Q3	$61.8M	Buy	396,550 +206,000	+108%	+$33.3M	0.03%	692
2024 Q2	$29.7M	Buy	190,550 +106,200	+126%	+$16M	0.01%	1160
2024 Q1	$11.4M	Buy	+84,350	New	+$11.2M	﹤0.01%	2061
2023 Q4	–	Sell	-316,750	Closed	-$42.9M	–	6077
2023 Q3	$42.9M	Buy	316,750 +127,650	+68%	+$17.4M	0.02%	810
2023 Q2	$27.1M	Sell	189,100 -177,900	-48%	-$26.2M	0.01%	1140
2023 Q1	$50.9M	Buy	367,000 +331,650	+938%	+$44.6M	0.03%	680
2022 Q4	$4.79M	Sell	35,350 -63,250	-64%	-$7.93M	﹤0.01%	2848
2022 Q3	$10.8M	Sell	98,600 -76,400	-44%	-$9.69M	0.01%	2032
2022 Q2	$23.1M	Buy	175,000 +75,000	+75%	+$9.84M	0.01%	1169
2022 Q1	$13.3M	Sell	100,000 -25,000	-20%	-$3M	0.01%	1819
2021 Q4	$14.6M	Buy	125,000 +113,050	+946%	+$13.3M	0.01%	1745
2021 Q3	$1.44M	Buy	+11,950	New	+$1.39M	﹤0.01%	4283
2021 Q1	–	Sell	-171,600	Closed	-$17.2M	–	5900
2020 Q4	$17.2M	Buy	+171,600	New	+$18.2M	0.01%	1200
2019 Q4	–	Sell	-225,300	Closed	-$20.1M	–	4196
2019 Q3	$20.1M	Buy	225,300 +199,700	+780%	+$17.3M	0.03%	784
2019 Q2	$2.11M	Sell	25,600 -99,400	-80%	-$7.79M	﹤0.01%	2372
2019 Q1	$10.1M	Sell	125,000 -250,000	-67%	-$19.7M	0.02%	1237
2018 Q4	$28.5M	Sell	375,000 -70,250	-16%	-$5.49M	0.04%	548
2018 Q3	$35.2M	Buy	445,250 +145,250	+48%	+$11M	0.04%	559
2018 Q2	$21.1M	Buy	+300,000	New	+$21.6M	0.03%	822
2017 Q3	–	Sell	-600,000	Closed	-$40.9M	–	3497
2017 Q2	$40.9M	Sell	600,000 -300,000	-33%	-$19.6M	0.07%	377
2017 Q1	$56.1M	Buy	900,000 +150,000	+20%	+$8.73M	0.1%	278
2016 Q4	$41M	Buy	750,000 +537,500	+253%	+$30.5M	0.09%	324
2016 Q3	$14M	Buy	+212,500	New	+$13.9M	0.02%	744
2016 Q1	–	Sell	-150,000	Closed	-$10.2M	–	3257
2015 Q4	$10.2M	Hold	150,000	–	–	0.02%	920
2015 Q3	$9.55M	Buy	+150,000	New	+$9.87M	0.02%	958
2015 Q2	–	Sell	-3,300	Closed	-$226K	–	3310
2015 Q1	$226K	Sell	3,300 -121,200	-97%	-$8.42M	﹤0.01%	3235
2014 Q4	$8.76M	Sell	124,500 -28,300	-19%	-$2.03M	0.02%	1080
2014 Q3	$10.9M	Sell	152,800 -51,300	-25%	-$3.75M	0.03%	821
2014 Q2	$15.2M	Buy	204,100 +2,900	+1%	+$210K	0.04%	607
2014 Q1	$13.1M	Buy	+201,200	New	+$13M	0.04%	649
2013 Q4	–	Sell	-151,800	Closed	-$7.88M	–	3440
2013 Q3	$7.88M	Buy	+151,800	New	+$7.62M	0.03%	835

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Millennium Management's AZN Position: Q1 2026 in Review

Millennium Management increased its AstraZeneca (AZN) stake by 8.7% in Q1 2026, buying an estimated $20.1M and bringing the position to 1,302,645 shares worth $257M. The position accounts for 0.11% of the portfolio, ranked #162.

Millennium Management first reported a position in AZN in Q2 2013 and has held it in 49 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Millennium Management held 1,302,645 shares of AstraZeneca worth $257M as of Q1 2026.
Millennium Management bought 104,173 AstraZeneca shares in Q1 2026, an estimated $20.1M.
AstraZeneca made up 0.11% of Millennium Management's portfolio in Q1 2026, its #162 holding.
Millennium Management first reported a position in AstraZeneca in Q2 2013 and has held it in 49 quarters since.
1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.